B³ Pharma
PrivateLast Round
Debt
Jun 4, 2019
Total Funding Raised
$15.7M
Company Overview
B³ Pharma operates in Healthcare & Life Sciences and is based in Canada. Its latest recorded funding round was a Debt round in June 2019.
B³ Pharma is a late-stage biopharma company advancing its Angiopep-drug conjugate platform to deliver therapies across the blood-brain barrier for the treatment of brain metastases and other CNS disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
B³ Pharma Comparables
Compare B³ Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gate2Brain | 78% | |
| Cybrexa Therapeutics | 77% | |
| Denali Therapeutics | 72% |
For institutional investors. Book with your work email.
B³ Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 4, 2019 | ||||
| Series C | Aug 1, 2018 | ||||
| Series A | Dec 16, 2005 |
For institutional investors. Book with your work email.
B³ Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2019
Secured $3M in debt financing led by Investissement Québec.
For institutional investors. Book with your work email.
B³ Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about B³ Pharma's valuation, stock price, and market status.
Is B³ Pharma a public or private company?
B³ Pharma is a private company.
What is the current stock price of B³ Pharma?
B³ Pharma is a private company, so its shares have no public market price. Caplight tracks B³ Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is B³ Pharma worth (valuation)?
Valuation information for B³ Pharma is not publicly available.
Can I buy B³ Pharma stock?
B³ Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was B³ Pharma's last funding round?
B³ Pharma's most recent funding round was Debt on June 4, 2019.
Who are the main investors in B³ Pharma?
Key investors in B³ Pharma include Investissement Québec.
Will B³ Pharma IPO soon?
No public IPO plans have been announced for B³ Pharma.
How can I track B³ Pharma secondary market activity?
Caplight tracks bids, offers, and trades in B³ Pharma's shares on secondary markets.